Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (435)	5/31/2004 1:44:43 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 12215

Whups, I see now that Wilder is okay with 25% cash, hey, cash is good. Heck, I'm 94% cash, it does give you terrific flexibility (if you don't know what to do with it) but I should think that, like Rocketman's portfolio, there should be enough ideas on SI to stay fully invested. The problem of course is that there can often be more ideas for purchases than sales, and a market downturn tends to lock a person into stale ideas. I see from the list so far, that there are five suggestions with a markecap around 1/2B. Two right around 170M, and one stock below 100m. Are these all small molecule in clinial trials? Ariad isn't really a classic GT stock anymore is it, and edit {is Viragen still talking about harvesting interferon from blood or is on to something equally offbeat?} Edit, oh, Valentis, gosh! To be honest, I did not recognize three of the symbols/names at first and I've never even heard of "CorAutus". I'll try to keep a low profile here, I guess I'm decidely out of touch!